OPSYNVI Trademark

Trademark Overview

On Tuesday, September 8, 2020, a trademark application was filed for OPSYNVI with the United States Patent and Trademark Office. The USPTO has given the OPSYNVI trademark a serial number of 90165717. The federal status of this trademark filing is REGISTERED as of Tuesday, January 2, 2024. This trademark is owned by Actelion Pharmaceuticals Ltd. The OPSYNVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of digital ulcers; pharmaceutical preparations for the treatment of glycolipid storage diseases; pharmaceutical preparations for the treatment of cerebrovascular diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical anti-allergic preparations and substances; anti-infectives
opsynvi

General Information

Serial Number90165717
Word MarkOPSYNVI
Filing DateTuesday, September 8, 2020
Status700 - REGISTERED
Status DateTuesday, January 2, 2024
Registration Number7257052
Registration DateTuesday, January 2, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of digital ulcers; pharmaceutical preparations for the treatment of glycolipid storage diseases; pharmaceutical preparations for the treatment of cerebrovascular diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical anti-allergic preparations and substances; anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 14, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameActelion Pharmaceuticals Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAllschwil CH-4123
CH
Party NameActelion Pharmaceuticals Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAllschwil CH-4123
CH
Party NameActelion Pharmaceuticals Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAllschwil CH-4123
CH

Trademark Events

Event DateEvent Description
Tuesday, January 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 2, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 14, 20231(B) BASIS DELETED; NEW BASIS REQUESTED
Wednesday, August 23, 2023NOTICE OF ALLOWANCE CANCELLED
Thursday, September 14, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, September 14, 2023PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, September 14, 2023ASSIGNED TO PETITION STAFF
Wednesday, August 23, 2023TEAS PETITION TO AMEND BASIS RECEIVED
Thursday, February 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 14, 2023SOU EXTENSION 4 GRANTED
Tuesday, February 14, 2023SOU EXTENSION 4 FILED
Tuesday, February 14, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 19, 2022SOU EXTENSION 3 GRANTED
Wednesday, October 19, 2022SOU EXTENSION 3 FILED
Wednesday, October 19, 2022SOU TEAS EXTENSION RECEIVED
Saturday, April 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 7, 2022SOU EXTENSION 2 GRANTED
Thursday, April 7, 2022SOU EXTENSION 2 FILED
Thursday, April 7, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 6, 2021SOU EXTENSION 1 GRANTED
Tuesday, July 6, 2021SOU EXTENSION 1 FILED
Tuesday, July 6, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 20, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 23, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 14, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 14, 2021ASSIGNED TO EXAMINER
Wednesday, October 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 11, 2020NEW APPLICATION ENTERED

Related Keywords

opsynvi preparations pharmaceutical treatment diseases anti disorders gastrointestinal cerebrovascular cardiovascular allergic